Hanne Primdahl

7PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSocial epidemiologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
The effect of progressive resistance training on lean soft tissue mass in head and neck cancer patients during concomitant chemoradiotherapy: the DAHANCA 31 randomized controlled trial.

|Aug 27, 2025
Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial.

Jacob Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen

|Aug 15, 2025
Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986-2020.

Pernille Lassen, Jan Alsner, Hanne Primdahl

|Oct 14, 2023
HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.

Jacob Kinggaard Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen

|Sep 06, 2023
Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA.

Maja Halgren Olsen, Thomas Maltesen, Pernille Lassen

|Dec 07, 2019
DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051).

M Saksø, H Primdahl, J Johansen

Pageof 2

Frequent Collaborators

6 joint publications

Jørgen Johansen

6 joint publications

Jens Overgaard

4 joint publications

Pernille Lassen

3 joint publications

Jesper Grau Eriksen